Table:
begin	end	state
1	44	cytoplasmic
45	67	transmembrane
68	79	non-cytoplasmic
80	100	transmembrane
101	133	cytoplasmic
134	153	transmembrane
154	161	non-cytoplasmic
162	184	transmembrane
185	190	cytoplasmic
191	210	transmembrane
211	224	non-cytoplasmic
225	248	transmembrane
249	256	cytoplasmic
257	277	transmembrane
278	282	non-cytoplasmic
283	301	transmembrane
302	320	cytoplasmic
321	341	transmembrane
342	371	non-cytoplasmic
372	395	transmembrane
396	406	cytoplasmic
407	434	transmembrane
435	456	non-cytoplasmic
457	474	transmembrane
475	505	cytoplasmic

Input:
>WP_012115873.1 NCBI__GCF_000017645.1:WP_012115873.1
MAHPPVADLKPEVLPKGDLPAPGLPGAPTLPPPTPHQGAASVIGSAFTDAIVSGLLTGLL
LLPLVGFRATESGSGPLGLTYRFGLVAVFAGIVAVLRLVLNLTVWRRGRKVKVSAGPSAF
TTLAQKAAPALRPAFFSFAIAYPFLAILLAGGLSPSRYWVDLGIYVLTYVMLGWGLNIVV
GLAGLLDLGYVAFYAVGAYTFALLSTSVPVNDFFAGHLGEGFWTAWSFWLCLPVSGLLAA
FWGVILGFPVLRLRGDYLAIVTLAFGEIIRLVLINWVSLTNGGAGISSIPPISFFGVPFN
ATDEGFAAKYGLDFDSMHRIIFLYFVILGLAALTALVTIRLRQMPVGRAWEALREDEIAC
RSLGINTTLTKLTAFATGAMFGGFAGAFFAVRVRFVSPESFTFMESAVILAIVVLGGMGS
QMGVAGAAILLIGGMEMLRNLSFLKADFLFGPDFDPSLYRMLIFGFAMVAVMVWRPRGLV
SSRLPTIFLKERKAVSSALVKEGHG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server